Publications about COVID-19 for Laboratories
Diagnostics
Genetic-based (i.e.,Nucleic Acid Amplification Test (NAAT))
US CDC real-time reverse transcription PCR panel for detection of Severe Acute Respiratory Syndrome Coronavirus 2
https://www.ncbi.nlm.nih.gov/pubmed/32396505external icon
Lu X, Wang L, Sakthive SKl, et al.
Emerg Infect Dis. 2020 Aug;26(8):1654-1665. doi: 10.3201/eid2608.201246.
Detection and genetic characterization of community-based SARS-CoV-2 infections—New York City, March 2020
https://www.ncbi.nlm.nih.gov/pubmed/32678072external iconBushmanexternal icon D, Alroyexternal icon KA, Greeneexternal icon SK, et al. MMWR Morb Mortal Wkly Rep. 2020 Jul 17;69(28):918-922. doi:10.15585/mmwr.mm6928a5.
Performance of oropharyngeal swab testing compared to nasopharyngeal swab testing for diagnosis of COVID-19 -United States, January-February 2020
https://www.ncbi.nlm.nih.gov/pubmed/32548635external icon
Patel MR, Carroll D, Ussery E, et al.
Clin Infect Dis. 2020 Jun 16;ciaa759. doi: 10.1093/cid/ciaa759.
Serological
Mesoscale reaction-diffusion phenomena governing lignin-first biomass fractionation
Thornburg N, Pecha M, Brandner D, et al. ChemSusChem. 2020 Apr 3. doi: 10.1002/cssc.202000558.
[Epub ahead of print] PMID: 32246557
Nature. 2020 Jun;582(7811):277-282. doi: 10.1038/s41586-020-2279-8.
Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillance
https://www.ncbi.nlm.nih.gov/pubmed/32511332external icon
Freeman B, Lester S, Mills L, et al.
bioRxiv. Preprint. 2020 Apr 25;2020.04.24.057323. doi: 10.1101/2020.04.24.057323
Sampling/Collection Methods
Bioaerosol sampling of a ventilated patient with COVID-19
https://pubmed.ncbi.nlm.nih.gov/32763347external icon
Lane MA, Brownsword EA, Morgan JS, et al.
Am J Infect Control. 2020 Aug 4;S0196-6553(20)30760-4. doi: 10.1016/j.ajic.2020.07.033.
Research
Clinical
Caution in identifying coronaviruses by electron microscopy
https://www.ncbi.nlm.nih.gov/pubmed/32651224external icon
Miller SE, Goldsmith CS
J Am Soc Nephrol. 2020 Sep;31(9):2223-2224. doi: 10.1681/ASN.2020050755.
Severe acute respiratory syndrome coronavirus 2 from patient with 2019 novel coronavirus disease, United States
Harcourt J, Tamin A, Lu X , et al.
Emerg Infect Dis. 2020 June. doi:10.3201/eid2606.200516.
Electron microscopy of SARS-CoV-2: a challenging task
https://www.ncbi.nlm.nih.gov/pubmed/32442529external icon
Goldsmith GS, Miller SE, Martines RB, et al.
Lancet. 2020 May 30;395(10238):e99. doi: 10.1016/S0140-6736(20)31188-0.
Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States
COVID-19 Investigation Team.
Nat Med. 2020 Apr 23. doi: 10.1038/s41591-020-0877-5. [Epub ahead of print] PMID: 32327757
Coronavirus Pathogenesis
Pathology and pathogenesis of SARS-CoV-2 associated with fatal Coronavirus disease, United States
https://www.ncbi.nlm.nih.gov/pubmed/32437316external icon
Martines RB, Ritter JM, Matkovic E, et al.
Emerg Infect Dis. 2020 Sep;26(9):2005-2015. doi: 10.3201/eid2609.202095.
Assessment of SARS-CoV-2 replication in the context of other respiratory viruses
https://www.ncbi.nlm.nih.gov/pubmed/32386570external icon
Belser JA
Lancet Respir Med. 2020 Jul;8(7):651-652. doi: 10.1016/S2213-2600(20)30227-7.
Virology
COVID-19 and the workplace: Research questions for the aerosol science community (Editorial)(Open Access)
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85088931860&doi=10.1080%2f02786826.2020.1796921&partnerID=40&md5=a4fc3c4695fd7ce1ecba1363b891828cexternal icon
Lindsley WG. Blachère FM, Burton NC, et al.
Aerosol Science and Technology. Volume 54, Issue 10, 2 October 2020, Pages 1117-1123
Persistence of bacteriophage Phi 6 on porous and nonporous surfaces and the potential for its use as an Ebola virus or Coronavirus surrogate
https://www.ncbi.nlm.nih.gov/pubmed/32591388external icon
Whitworth C, Mu Y, Houston H, et al.
Appl Environ Microbiol. 2020 Aug 18;86(17):e01482-20. doi: 10.1128/AEM.01482-20.
Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1
van Doremalen N, Bushmaker T, Morris, D, et al.
N Engl J Med. 2020 April 16;382(16), 1564-1567. doi:10.1056/
Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient
https://www.ncbi.nlm.nih.gov/pubmed/32511316external icon
Harcourt J, Tamin A, Lu X, et al.
bioRxiv. 2020 Mar 7;2020.03.02.972935. doi: 10.1101/2020.03.02.972935.
Serology
Seroprevalence of SARS-CoV-2 among frontline health care personnel in a multistate hospital network – 13 Academic Medical Centers, April-June 2020
https://pubmed.ncbi.nlm.nih.gov/32881855external icon
Self WH, Tenforde MW, Stubblefield WB, et al.
MMWR Morb Mortal Wkly Rep. 2020 Sep 4;69(35):1221-1226. doi: 10.15585/mmwr.mm6935e2
Estimated community seroprevalence of SARS-CoV-2 antibodies—Two Georgia counties, April 28-May 3, 2020
https://www.ncbi.nlm.nih.gov/pubmed/32701941external icon
Biggs HM, Harris JB, Breakwell Let al.
MMWR Morb Mortal Wkly Rep. 2020 Jul 24;69(29):965-970. doi: 10.15585/mmwr.mm6929e2.
Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23-May 12, 2020
https://pubmed.ncbi.nlm.nih.gov/32692365external icon
Havers FP, Reed C, Lim T, et al.
JAMA Intern Med. 2020 Jul 21. doi: 10.1001/jamainternmed.2020.4130.
Seroprevalence of SARS-CoV-2 among frontline healthcare personnel during the first month of caring for COVID-19 patients – Nashville, Tennessee
https://www.ncbi.nlm.nih.gov/pubmed/32628750external icon
Stubblefield WB, Talbot HK, Feldstein L, et al.
Clin Infect Dis. 2020 Jul 6;ciaa936. doi: 10.1093/cid/ciaa936.
SARS-CoV-2 infections and serologic responses from a sample of U.S. Navy Service members – USS Theodore Roosevelt, April 2020
https://www.ncbi.nlm.nih.gov/pubmed/32525850external icon
Payne DC, Smith-Jeffcoat SE, owak G, et al.
MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):714-721. doi: 10.15585/mmwr.mm6923e4.
Treatment
Antivirals
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
Sheahan T, Sims A, Zhou S, et al.
Sci Transl Med. 2020 Apr 29;12(541). pii: eabb5883. doi: 10.1126/scitranslmed.abb5883. Epub 2020 Apr 6. PMID: 32253226
Molecular Epidemiology
Genomic surveillance reveals multiple introductions of SARS-CoV-2 into Northern California
https://www.ncbi.nlm.nih.gov/pubmed/32513865external icon
Deng X, GuW Federman S, et al.
Science. 2020 Jul 31;369(6503):582-587. doi: 10.1126/science.abb9263.
Ten recommendations for supporting open pathogen genomic analysis in public health
https://www.ncbi.nlm.nih.gov/pubmed/32528156external icon
Black A, MacCannell DR, Sibley TR, et al.
Nat Med. 2020 Jun;26(6):832-841. doi: 10.1038/s41591-020-0935-z.
Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillance
https://www.ncbi.nlm.nih.gov/pubmed/32511332external icon
Freeman B, Lester S, Mills L, et al.
bioRxiv. 2020 Apr 25;2020.04.24.057323. doi: 10.1101/2020.04.24.057323
First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SAR-CoV-2) in the USA
Ghinai I, McPherson T, Hunter J, et al.
The Lancet. Published online March 12, 2020. doi: https: 10.1016/S0140-6736(20)30607-3
CDC is not responsible for the content of the external publications or resources included in this list, nor does CDC endorse the information contained in external links. It is the responsibility of the user to examine the copyright and licensing restrictions of external posted publications or information; users cannot assume that the external sites will abide by the same privacy provisions as those hosted by CDC.